HealthWell Foundation — Macular Degeneration (Wet and Dry) Fund

Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.

Maximum award Up to $4,000 · Income ≤500% FPL · Covers drug cost only — administration billed separately

CLOSED
Status verified June 11, 2026 · Source: HealthWell Foundation fund page ↗
cron 2026-05-01: data-status="closed" data-fund-id=188358

Fund facts

Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.

Assistance type
Copay Grant
Maximum award
Up to $4,000
What it covers
Covers drug cost only — administration billed separately
Income limit
≤500% FPL
Insurance
commercial medicare medicaid tricare
Diagnosis required
Macular Degeneration (Wet and Dry) (confirmed diagnosis)
Residency
US resident
ICD-10
H35.3 H35.30 H35.31 H35.32
Processing time
5–10 business days
Renewal
annual reapplication
Fund availability depends on donations. May close and reopen periodically.

Covered drugs in our billing library

Drugs whose J-codes this fund matches. Each links to its billing & coding reference.

Published formulary

The foundation's own covered-medication list for this fund (39 drugs). Confirm coverage of your exact NDC at application.

Show all 39 covered medications
  • Aflibercept
  • Aflibercept-ayyh
  • Alymsys
  • Ascorbic Acid
  • Avacincaptad Pegol Sodium
  • Avastin
  • Beovu
  • Beta Carotene
  • Bevacizumab
  • Bevacizumab-adcd
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • Bevacizumab-maly
  • Brolucizumab-dbll
  • Byooviz
  • Cimerli
  • Empaveli
  • Eylea
  • Eylea Hd
  • Faricimab-svoa
  • Izervay
  • Lucentis
  • Mvasi
  • Natural Mixed Tocopherols
  • Pavblu
  • Pegcetacoplan
  • Ranibizumab
  • Ranibizumab-eqrn
  • Ranibizumab-nuna
  • Susvimo
  • Syfovre
  • Thalidomide
  • Thalomid
  • Vabysmo
  • Vegzelma
  • Verteporfin
  • Visudyne
  • Vitamin E (non Otc)
  • Zirabev

This fund is closed — here's the move

Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.

Manufacturer copay programs may also apply — see the drug pages: Eylea HD, Eylea, Beovu, Lucentis / biosimilars.

Other funds covering these drugs

Status shown as of each fund's last verification.

Common questions

Is the HealthWell Foundation Macular Degeneration (Wet and Dry) fund open?

As of June 11, 2026, the HealthWell Foundation Macular Degeneration (Wet and Dry) fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 800-675-8416.

How much assistance does the Macular Degeneration (Wet and Dry) fund provide?

Up to $4,000. Covers drug cost only — administration billed separately

What are the income limits for the Macular Degeneration (Wet and Dry) fund?

Household income must be ≤500% FPL. US resident.

What insurance does the Macular Degeneration (Wet and Dry) fund accept?

Accepted: commercial, medicare, medicaid, tricare.

How long does the Macular Degeneration (Wet and Dry) fund take to process an application?

The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.

Patient or caregiver? Show this page to your infusion center's financial counselor — they can check what you'd qualify for and apply on your behalf, or call HealthWell Foundation at 800-675-8416.